TREA

90065058 - SYNGENE SYNVENT

Follow

Information

  • Trademark
  • 90065058
  • Serial Number
    90065058
  • Registration Number
    6695032
  • Filing Date
    July 21, 2020
    4 years ago
  • Registration Date
    April 05, 2022
    2 years ago
  • Transaction Date
    April 05, 2022
    2 years ago
  • Status Date
    April 05, 2022
    2 years ago
  • Published for Opposition Date
    June 01, 2021
    3 years ago
  • Location Date
    March 03, 2022
    2 years ago
  • First Use Anywhere Date
    August 11, 2021
    3 years ago
  • First Use In Commerce Date
    August 11, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BLACK, MILDRED ELIZABE
  • Attorney Docket Number
    077752-06
    Attorney Name
    Mark A. Watkins
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
SYNGENE SYNVENT
Case File Statements
  • DM0000: The mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle.
  • GS0441: Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes
  • GS0421: Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry
Case File Event Statements
  • 4/5/2022 - 2 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/4/2022 - 2 years ago
    25 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 3/3/2022 - 2 years ago
    24 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 2/15/2022 - 2 years ago
    23 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 1/27/2022 - 2 years ago
    22 - USE AMENDMENT FILED Type: IUAF
  • 2/14/2022 - 2 years ago
    21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/27/2022 - 2 years ago
    20 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 7/27/2021 - 3 years ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/1/2021 - 3 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/1/2021 - 3 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/12/2021 - 3 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/29/2021 - 3 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/29/2021 - 3 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/29/2021 - 3 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/29/2021 - 3 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/29/2021 - 3 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/9/2020 - 3 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/9/2020 - 3 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/9/2020 - 3 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/4/2020 - 3 years ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/19/2020 - 4 years ago
    6 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/18/2020 - 4 years ago
    5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/29/2020 - 4 years ago
    4 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/29/2020 - 4 years ago
    3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/29/2020 - 4 years ago
    2 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/24/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP